Published in J Cell Biochem on June 01, 2015
A Children's Oncology Group and TARGET initiative exploring the genetic landscape of Wilms tumor. Nat Genet (2017) 1.38
Recent developments in epigenetics of acute and chronic kidney diseases. Kidney Int (2015) 0.88
Epigenetics mechanisms in renal development. Pediatr Nephrol (2015) 0.78
High-resolution profiling of histone methylations in the human genome. Cell (2007) 85.74
An integrated encyclopedia of DNA elements in the human genome. Nature (2012) 64.73
The language of covalent histone modifications. Nature (2000) 44.92
Human DNA methylomes at base resolution show widespread epigenomic differences. Nature (2009) 34.27
Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science (2009) 32.97
Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell (2007) 30.22
Histone modifications at human enhancers reflect global cell-type-specific gene expression. Nature (2009) 24.41
Mapping and analysis of chromatin state dynamics in nine human cell types. Nature (2011) 24.37
Long non-coding RNAs: insights into functions. Nat Rev Genet (2009) 19.61
The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain. Science (2009) 18.82
The accessible chromatin landscape of the human genome. Nature (2012) 16.86
Transcriptional maps of 10 human chromosomes at 5-nucleotide resolution. Science (2005) 16.82
The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Res (2012) 15.41
A unique chromatin signature uncovers early developmental enhancers in humans. Nature (2010) 14.02
The NIH Roadmap Epigenomics Mapping Consortium. Nat Biotechnol (2010) 13.99
Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Nature (2011) 13.94
Polycomb proteins targeted by a short repeat RNA to the mouse X chromosome. Science (2008) 13.79
ChIP-seq guidelines and practices of the ENCODE and modENCODE consortia. Genome Res (2012) 9.13
Regulation of alternative splicing by histone modifications. Science (2010) 7.98
Charting histone modifications and the functional organization of mammalian genomes. Nat Rev Genet (2010) 7.39
Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position. Nat Methods (2013) 7.06
Global epigenomic reconfiguration during mammalian brain development. Science (2013) 6.14
Six2 defines and regulates a multipotent self-renewing nephron progenitor population throughout mammalian kidney development. Cell Stem Cell (2008) 5.76
Identification of 67 histone marks and histone lysine crotonylation as a new type of histone modification. Cell (2011) 5.27
Wnt9b plays a central role in the regulation of mesenchymal to epithelial transitions underlying organogenesis of the mammalian urogenital system. Dev Cell (2005) 4.91
PTIP associates with MLL3- and MLL4-containing histone H3 lysine 4 methyltransferase complex. J Biol Chem (2007) 4.79
An operational definition of epigenetics. Genes Dev (2009) 4.26
Chromatin-modifying enzymes as modulators of reprogramming. Nature (2012) 4.22
An X chromosome gene, WTX, is commonly inactivated in Wilms tumor. Science (2007) 4.00
Genome-wide chromatin state transitions associated with developmental and environmental cues. Cell (2013) 3.83
Patterning a complex organ: branching morphogenesis and nephron segmentation in kidney development. Dev Cell (2010) 3.78
TET enzymes, TDG and the dynamics of DNA demethylation. Nature (2013) 3.49
Pax-2 controls multiple steps of urogenital development. Development (1995) 3.42
Six2 is required for suppression of nephrogenesis and progenitor renewal in the developing kidney. EMBO J (2006) 3.26
Reversing DNA methylation: mechanisms, genomics, and biological functions. Cell (2014) 3.17
Interplay between the cancer genome and epigenome. Cell (2013) 3.05
Immunogenetics. Chromatin state dynamics during blood formation. Science (2014) 2.99
X-inactivation, imprinting, and long noncoding RNAs in health and disease. Cell (2013) 2.96
Aberrant epigenetic landscape in cancer: how cellular identity goes awry. Dev Cell (2010) 2.86
Targeting epigenetic readers in cancer. N Engl J Med (2012) 2.86
Genome-wide chromatin maps derived from limited numbers of hematopoietic progenitors. Nat Methods (2010) 2.71
FGF9 and FGF20 maintain the stemness of nephron progenitors in mice and man. Dev Cell (2012) 2.43
ASXL1 mutations promote myeloid transformation through loss of PRC2-mediated gene repression. Cancer Cell (2012) 2.42
The BRCT-domain containing protein PTIP links PAX2 to a histone H3, lysine 4 methyltransferase complex. Dev Cell (2007) 2.20
Canonical Wnt9b signaling balances progenitor cell expansion and differentiation during kidney development. Development (2011) 1.92
Six2 and Wnt regulate self-renewal and commitment of nephron progenitors through shared gene regulatory networks. Dev Cell (2012) 1.75
Whole-genome chromatin profiling from limited numbers of cells using nano-ChIP-seq. Nat Protoc (2011) 1.74
Chromatin "prepattern" and histone modifiers in a fate choice for liver and pancreas. Science (2011) 1.70
Single-tube linear DNA amplification (LinDA) for robust ChIP-seq. Nat Methods (2011) 1.60
Wilms tumor chromatin profiles highlight stem cell properties and a renal developmental network. Cell Stem Cell (2010) 1.34
Embryonic development following somatic cell nuclear transfer impeded by persisting histone methylation. Cell (2014) 1.18
Notch pathway activation can replace the requirement for Wnt4 and Wnt9b in mesenchymal-to-epithelial transition of nephron stem cells. Development (2011) 1.10
Nuclear accumulation of beta-catenin protein in Wilms' tumours. J Pathol (2003) 1.08
Epigenetics: Unravelling the cancer code. Nature (2011) 1.02
Distinct dynamics and distribution of histone methyl-lysine derivatives in mouse development. Dev Biol (2004) 0.99
Glimpses of the epigenetic landscape. Cell Stem Cell (2009) 0.89
Histone signature of metanephric mesenchyme cell lines. Epigenetics (2013) 0.82
In situ histone landscape of nephrogenesis. Epigenetics (2013) 0.81
The genetics and epigenetics of kidney development. Semin Nephrol (2013) 0.80
Epigenetics in kidney development and renal disease. Transl Res (2014) 0.80
Patterning and early cell lineage decisions in the developing kidney: the role of Pax genes. Pediatr Nephrol (2011) 0.79
Chromatin-based mechanisms of renal epithelial differentiation. J Am Soc Nephrol (2011) 0.79
Combinatorial control of the bradykinin B2 receptor promoter by p53, CREB, KLF-4, and CBP: implications for terminal nephron differentiation. Am J Physiol Renal Physiol (2005) 1.70
Histone deacetylase (HDAC) activity is critical for embryonic kidney gene expression, growth, and differentiation. J Biol Chem (2011) 1.14
Regulation of 3-phosphoinositide-dependent protein kinase-1 (PDK1) by Src involves tyrosine phosphorylation of PDK1 and Src homology 2 domain binding. J Biol Chem (2007) 1.08
Role of the renin-angiotensin system in the development of the ureteric bud and renal collecting system. Pediatr Nephrol (2005) 1.06
Angiotensin II type 1 receptor-EGF receptor cross-talk regulates ureteric bud branching morphogenesis. J Am Soc Nephrol (2006) 1.06
Association of LETM1 and MRPL36 contributes to the regulation of mitochondrial ATP production and necrotic cell death. Cancer Res (2009) 1.05
PHF20 regulates NF-κB signalling by disrupting recruitment of PP2A to p65. Nat Commun (2013) 1.02
p53 regulates metanephric development. J Am Soc Nephrol (2009) 0.99
A role for p53 in terminal epithelial cell differentiation. J Clin Invest (2002) 0.99
Regulation of OPA1-mediated mitochondrial fusion by leucine zipper/EF-hand-containing transmembrane protein-1 plays a role in apoptosis. Cell Signal (2009) 0.98
Cucurbitacin induces autophagy through mitochondrial ROS production which counteracts to limit caspase-dependent apoptosis. Autophagy (2012) 0.98
Spatial repression of PCNA by p53 during kidney development. Am J Physiol Renal Physiol (2002) 0.92
Tight regulation of p53 activity by Mdm2 is required for ureteric bud growth and branching. Dev Biol (2011) 0.92
MicroRNA-21 stimulates gastric cancer growth and invasion by inhibiting the tumor suppressor effects of programmed cell death protein 4 and phosphatase and tensin homolog. J BUON (2014) 0.90
DWARF14 is a non-canonical hormone receptor for strigolactone. Nature (2016) 0.90
A genome-wide analysis of lentivector integration sites using targeted sequence capture and next generation sequencing technology. Infect Genet Evol (2012) 0.90
Downregulation of Spry-1, an inhibitor of GDNF/Ret, causes angiotensin II-induced ureteric bud branching. Kidney Int (2008) 0.89
Spatiotemporal switch from DeltaNp73 to TAp73 isoforms during nephrogenesis: impact on differentiation gene expression. J Biol Chem (2005) 0.89
DNA-dependent protein kinase-mediated phosphorylation of protein kinase B requires a specific recognition sequence in the C-terminal hydrophobic motif. J Biol Chem (2009) 0.89
Cross-talk of the renin-angiotensin and kallikrein-kinin systems. Biol Chem (2006) 0.89
The polycystic kidney disease-1 gene is a target for p53-mediated transcriptional repression. J Biol Chem (2006) 0.88
Heat shock protein 70-mediated sensitization of cells to apoptosis by Carboxyl-Terminal Modulator Protein. BMC Cell Biol (2009) 0.88
Two functionally divergent p53-responsive elements in the rat bradykinin B2 receptor promoter. J Biol Chem (2003) 0.88
The Bradykinin B2 receptor gene is a target of angiotensin II type 1 receptor signaling. J Am Soc Nephrol (2007) 0.88
Angiotensin II AT2 receptor regulates ureteric bud morphogenesis. Am J Physiol Renal Physiol (2009) 0.88
A p53-Pax2 pathway in kidney development: implications for nephrogenesis. PLoS One (2012) 0.86
Gene transfer of c-met confers protection against D-galactosamine/lipopolysaccharide-induced acute liver failure. Dig Dis Sci (2012) 0.85
Regulation of kidney development by histone deacetylases. Pediatr Nephrol (2011) 0.83
Genome-wide analysis of the p53 gene regulatory network in the developing mouse kidney. Physiol Genomics (2013) 0.83
Susceptibility to metanephric apoptosis in bradykinin B2 receptor null mice via the p53-Bax pathway. Am J Physiol Renal Physiol (2006) 0.83
Histone signature of metanephric mesenchyme cell lines. Epigenetics (2013) 0.82
Mechanisms of p53 activation and physiological relevance in the developing kidney. Am J Physiol Renal Physiol (2012) 0.82
Receptor tyrosine kinases in kidney development. J Signal Transduct (2011) 0.82
A novel pathological role of p53 in kidney development revealed by gene-environment interactions. Am J Physiol Renal Physiol (2004) 0.82
Genetic inactivation of the B2 receptor in mice worsens two-kidney, one-clip hypertension: role of NO and the AT2 receptor. J Hypertens (2003) 0.82
Comparison of the anti-inflammatory and analgesic effects of Gentiana macrophylla Pall. and Gentiana straminea Maxim., and identification of their active constituents. J Ethnopharmacol (2012) 0.82
The Bradykinin B2 receptor is required for full expression of renal COX-2 and renin. Peptides (2003) 0.82
Renal and blood pressure phenotype in 18-mo-old bradykinin B2R(-/-)CRD mice. Am J Physiol Regul Integr Comp Physiol (2003) 0.81
High levels of aromatic amino acids in gastric juice during the early stages of gastric cancer progression. PLoS One (2012) 0.80
Histone deacetylases in kidney development: implications for disease and therapy. Pediatr Nephrol (2012) 0.79
Atypical hemolytic-uremic syndrome in a child presenting with malignant hypertension. Clin Pediatr (Phila) (2011) 0.78
Angiotensin II regulates growth of the developing papillas ex vivo. Am J Physiol Renal Physiol (2012) 0.78
Enterohepatic Helicobacter Species as a Potential Causative Factor in Inflammatory Bowel Disease: A Meta-Analysis. Medicine (Baltimore) (2015) 0.78
A novel bioassay for detecting GPCR heterodimerization: transactivation of beta 2 adrenergic receptor by bradykinin receptor. J Biomol Screen (2010) 0.78
Intron-derived aberrant splicing of A20 transcript in rheumatoid arthritis. Rheumatology (Oxford) (2012) 0.77
Synthesis of tamarixetin and isorhamnetin 3-O-neohesperidoside. Carbohydr Res (2005) 0.75
A child with Wegener's granulomatosis and severe hemophilia A: interplay of disease processes. Clin Pediatr (Phila) (2010) 0.75
[Treatment of triangular fibrocartilage complex tear under wrist arthroscopy]. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi (2011) 0.75
[Litterfall in main forest ecosystems of Northeast China]. Ying Yong Sheng Tai Xue Bao (2005) 0.75
Characterization of fragmented 3-phosphoinsitide-dependent protein kinase-1 (PDK1) by phosphosite-specific antibodies. Life Sci (2013) 0.75
p63+ ureteric bud tip cells are progenitors of intercalated cells. JCI Insight (2017) 0.75
Synthesis of 3-O-(beta-D-xylopyranosyl-(1-->2)-beta-D-glucopyranosyl)-3'-O-(beta-D-glucopyranosyl)tamarixetin, the putative structure of aescuflavoside A from the seeds of Aesculus chinensis. Carbohydr Res (2006) 0.75